A study on women with Down syndrome found a correlation between lower endogenous levels of estradiol post-menopause and higher risk of developing AD (144). Estradiol modulates serotonin signaling (145), and low levels of estradiol-target BDNF are correlated with depression onset (146). Here, BDNF is linked to depressive symptom measurement.